PNC Financial Services Group Inc. Trims Stock Holdings in GE HealthCare Technologies Inc. $GEHC

PNC Financial Services Group Inc. lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 187,253 shares of the company’s stock after selling 16,255 shares during the quarter. PNC Financial Services Group Inc.’s holdings in GE HealthCare Technologies were worth $13,329,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the last quarter. Auto Owners Insurance Co boosted its holdings in shares of GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after purchasing an additional 33,629,559 shares during the period. Dodge & Cox increased its position in shares of GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after purchasing an additional 3,693,918 shares during the last quarter. Capital Research Global Investors raised its holdings in GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after buying an additional 389,796 shares during the period. Finally, State Street Corp raised its holdings in GE HealthCare Technologies by 2.0% during the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after buying an additional 401,932 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Kevin Lobo bought 10,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 22nd. The stock was purchased at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the acquisition, the director directly owned 14,363 shares in the company, valued at approximately $921,817.34. This trade represents a 229.20% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Watkin Phoebe L. Yang bought 1,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 8th. The shares were acquired at an average cost of $63.01 per share, with a total value of $63,010.00. Following the acquisition, the director owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders have acquired 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is owned by corporate insiders.

GE HealthCare Technologies Stock Performance

GEHC opened at $60.58 on Friday. The company has a market cap of $27.56 billion, a P/E ratio of 14.49, a price-to-earnings-growth ratio of 1.65 and a beta of 0.72. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The firm’s 50-day moving average price is $63.63 and its 200-day moving average price is $71.23. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same period in the prior year, the firm posted $1.01 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is 3.35%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Wells Fargo & Company cut their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research note on Thursday, April 30th. Hovde Group assumed coverage on GE HealthCare Technologies in a research note on Friday, July 17th. They set a “market perform” rating and a $14.00 price target for the company. Weiss Ratings cut GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. Piper Sandler cut their price objective on GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Finally, Jefferies Financial Group reduced their target price on GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $76.41.

GE HealthCare Technologies News Roundup

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported preliminary second-quarter 2026 results and reaffirmed its full-year guidance, which suggests the business is still tracking in line with expectations and may be seeing momentum in key areas. GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
• Positive Sentiment: The company’s revenue outlook appears steady, with Q2 revenue guidance roughly in line with Wall Street estimates, and management has indicated that second-half performance could improve as cost pressures ease. Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
• Neutral Sentiment: GE HealthCare announced that CFO Jay Saccaro will step down, but the company framed the move as a transition rather than a crisis, which makes the near-term market impact uncertain. GE HealthCare CFO to step down
• Negative Sentiment: Ongoing securities-fraud investigations and shareholder-loss solicitations add legal uncertainty and can weigh on sentiment toward GEHC stock. GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
• Negative Sentiment: Another law firm expanded a securities-fraud probe tied to prior disclosures, reinforcing investor concerns about possible litigation risk. Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
• Negative Sentiment: GE HealthCare was downgraded by Zacks Research from “hold” to “strong sell,” which may add to selling pressure. Zacks Research downgrade

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.